Search clinical trials for: Inactivated Split-virion influenza vaccine

Total 11297 results

French National Agency for Research on AIDS and...
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Antibody Responses to Pneumococcal Vaccines Among HIV-Infected Adults.

HIV Infections
Genitope Corporation

Terminated

Personalized Active Immunotherapy (Vaccine Therapy) and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma

Non-Hodgkin's Lymphoma

United States
Novartis
Novartis Vaccines

Completed

Study of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy Children

Encephalitis, Tick-Borne

Germany
International Vaccine Institute
Wellcome Trust; Centers for Disease Control and Prevention; University of Western... and other collaborators

Completed

Typhoid Vi Vaccine Effectiveness in Hechi, Guangxi, China

Typhoid | Paratyphoid Fever

China
International Vaccine Institute
GlaxoSmithKline; Wellcome Trust; National Institute of Hygiene and Epidemiology... and other collaborators

Completed

Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue City, Central Vietnam

Typhoid | Paratyphoid Fever

Vietnam
Solvay Pharmaceuticals

Completed

Vasomotoric Symptoms Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone Combination

Postmenopause

Croatia, France, Poland, Romania, Russian Federation
National Institutes of Health Clinical Center (CC)

Completed

Plasmapheresis of Anthrax-Vaccinated Subjects for Production of Anthrax Immune Globulin

Anthrax

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of gp100 Human Melanoma Peptide Vaccine With Incomplete Freund's Adjuvant

Melanoma

United States
National Cancer Institute (NCI)

Completed

A Pilot Study of the Patterns of Cellular Gene Expression in HIV-1 Patients Following Clinical Events Which Increase Plasma Virus Concentrations

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Phase I Study of APL 400-003, a Candidate HIV Vaccine, in HIV-Negative Volunteers

Acquired Immunodeficiency Syndrome | HIV Infection

United States
National Cancer Institute (NCI)

Completed

Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and Tyrosinase

Melanoma | Neoplasm Metastasis

United States
National Institutes of Health Clinical Center (CC)

Completed

Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer

Nasopharyngeal Neoplasms

United States
National Institute of Allergy and Infectious Diseases...

Completed

HIV-1 Vaccine Test in Uninfected Adult Volunteers

Healthy | HIV Seronegativity

United States
National Institute of Allergy and Infectious Diseases...

Completed

Phase I/II Trial of Modified Vaccinia Virus Ankara (MVA) Vaccine Against Smallpox

Healthy

United States
National Institute of Allergy and Infectious Diseases...

Completed

Phase I Trial of Smallpox Vaccine

Healthy

United States
National Institute of Allergy and Infectious Diseases...

Completed

Mechanisms of Allergen Immunotherapy

Hypersensitivity | Asthma

United States
National Institute of Allergy and Infectious Diseases...

Completed

Comparison of Immune Response to Booster Vaccines in Blood Transplant Patients and Healthy Volunteers

Healthy | Stem Cell Transplantation | Active Immunity

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Immunogenicity of a Vaccine for Cutaneous Leishmaniasis Using Recombinant Human Interleukin-12 and Aluminum Hydroxide Gel as Adjuvants

Cutaneous Leishmaniasis

United States
National Cancer Institute (NCI)

Completed

Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapy

Neoplasm Metastasis | Breast Neoplasm

United States
National Cancer Institute (NCI)

Completed

Prediction and Testing of Antigenic Sites of the AIDS Virus, HTLV-III Recognized by T Lymphocytes for the Development of Synthetic Vaccines

HIV Infections | Healthy

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of Recombinant Vaccinia Virus That Expresses Prostate Specific Antigen in Adult Patients With Adenocarcinoma of the Prostate

Prostatic Neoplasms

United States
National Cancer Institute (NCI)

Completed

Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection

Acquired Immunodeficiency Syndrome | HIV Infection

United States
Mackay Memorial Hospital

Unknown

Impaired Immunity in Patients With Cancer: Influence of Cancer Stage, Chemotherapy, and Cytomegalovirus Infection

Neoplasms

Taiwan
National Institute on Deafness and Other Communication...

Completed

Maternal Immunization To Prevent Infant Otitis Media

Otitis Media

United States
Texas Heart Institute
POM Wonderful LLC

Completed

Pomegranate Products for Prevention of Common Cold

Cough | Fever | Influenza | Headache | Common Cold

United States
Kern Medical Center
Medical Diagnostic Laboratories, LLC; Copan Innovation Murrietta, CA

Unknown

Comparison of Nylon Flocked Swabs and Saline Aspirates for Detection Respiratory Viruses

Influenza | Bronchiolitis | Respiratory Syncytial Virus | Pediatric | Human Metapneumovirus
BioCryst Pharmaceuticals

Withdrawn

Intramuscular Peramivir for the Treatment of Uncomplicated Influenza

Influenza
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Terminated

Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer

Lung Cancer

United States
Quidel Corporation

Completed

QuickVue Influenza A+B Clinical Field Trial

Influenza

Australia
Oncothyreon Canada Inc.

Completed

Safety and Immunological Response Rate Study of THERATOPE® Vaccine in Metastatic Breast Cancer Patients

Breast Neoplasms

United States
National Institute of Allergy and Infectious Diseases...
Johns Hopkins Bloomberg School of Public Health

Completed

Safety of and Immune Response to a Dengue Virus Vaccine (rDEN2/4delta30[ME]) in Healthy Adults

Dengue Fever

United States
National Institute of Allergy and Infectious Diseases...
Johns Hopkins Bloomberg School of Public Health

Completed

Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults

Tick-Borne Encephalitis

United States
National Institute of Allergy and Infectious Diseases...
Johns Hopkins Bloomberg School of Public Health

Completed

Safety of and Immune Response to a Malaria Vaccine (MSP1 42-C1) With or Without CPG 7909 Adjuvant

Malaria

United States
National Institute of Allergy and Infectious Diseases...
Johns Hopkins Bloomberg School of Public Health

Completed

Safety of and Immune Response to a Dengue Virus Vaccine (rDEN1delta30) in Healthy Adults

Dengue Fever

United States
Forest Laboratories

Completed

Study Evaluating RGH-188 in the Treatment of Patients With Schizophrenia

Schizophrenia

United States
Nabi Biopharmaceuticals

Terminated

Evaluation of a Third and Fourth Dose of StaphVAX® in Adults With End-Stage Renal Disease (SHIELD-2)

Staphylococcal Infections | Chronic Kidney Failure

United States
Nabi Biopharmaceuticals

Completed

StaphVAX Immunogenicity in Orthopedic Implant Patients

Staphylococcal Infections | Joint Prosthesis

United States
Nabi Biopharmaceuticals

Completed

Evaluation of Manufacturing Lot of StaphVAX

Staphylococcal Infections | Chronic Kidney Failure

United States
Herlev Hospital

Terminated

Dendritic Cell Based Therapy of Metastatic Breast Cancer

Metastatic Breast Cancer

Denmark
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Safety and Local Tolerability of Prevenar in Indian Children

Pneumococcal Infections
National Institute of Allergy and Infectious Diseases...

Completed

GAS Epi Study to Measure Age-Related Antibody Titers to J8 Vaccine

Streptococcus Group A

Fiji
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Prevenar Immunogenicity in High Risk Children

Vaccines, Pneumococcal Conjugate Vaccine
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Prevenar® to Pneumo 23 in Reducing Carriage in Children

Vaccines, Pneumococcal | Vaccines, Pneumococcal Conjugate Vaccine
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety and Ability to Produce Immune Response of Prevenar and Meningitec Given at the Same Time

Healthy
Cell Genesys

Completed

Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia

Acute Myelogenous Leukemia

United States
Cell Genesys

Completed

A Cancer Vaccine (CG8123) Given With and Without Cyclophosphamide for Advanced Stage Non-Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung | Lung Cancer
Cell Genesys

Completed

Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine

Prostate Cancer

United States
Epimmune
Pharmexa A/S; Pharmexa-Epimmune

Unknown

A Phase 1 Safety and Immunogenicity Study of the Epitope Based DNA Vaccine (EP HIV-1090) in HIV-1 Infected Individuals Receiving Antiretroviral Therapy (ART) (EP1090)

HIV Infections

United States
Cell Genesys

Completed

Vaccination in the Peripheral Stem Cell Transplant Setting for Multiple Myeloma

Multiple Myeloma

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Streptococcus Pneumoniae Nasopharyngeal Carriage Rate in Children Receiving Prevnar®

Pneumococcal Infections

Search clinical trials for: Inactivated Split-virion influenza vaccine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Oman

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations